Hikma Pharmaceuticals PLC (H5P F) stock market data APIs
€18.0406
0.1(0.6%)
as of January 16, 2026
Try our APIs with
free plan!
Hikma Pharmaceuticals PLC Financial Data Overview
Price chart is built with
Anychart
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Prev. Close
18.0406
Open
18.141
High
18.6897
Low
18.0398
52 wk Range
17.2-27.5235
Market Cap
4 030 M
P/E Ratio
12.6389
Shares Outstanding
221 M
Revenue
3 216 M
Dividends (Yield)
0.0464
Beta
0.729
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Hikma Pharmaceuticals PLC data using free add-ons & libraries
Get Hikma Pharmaceuticals PLC Fundamental Data
Hikma Pharmaceuticals PLC Fundamental data includes:
- Net Revenue: 3 216 M
- EBITDA: 764 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Hikma Pharmaceuticals PLC News
New
Par Health Names Dr. William Larkins as EVP and Chief Scientific Officer and President, Sterile Injectables
Appointment Enhances Leadership Team with Deep Sterile Injectables Expertise and Ability to Drive the Company's Global R&D Strategy and Execution ST. LOUIS, Jan. 12, 2026 /PRNewswire/ -- Par Health, ...
Looking At The Narrative For Hikma Pharmaceuticals LSE HIK After Analyst Split On Fair Value
Hikma Pharmaceuticals’ fair value estimate has been nudged down from £22.66 to £22.00 per share, a small adjustment that better reflects the current mix of bullish and bearish analyst targets. The...
Hikma Pharmaceuticals (LON:HIK) shareholders have endured a 29% loss from investing in the stock five years ago
The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results between individual stocks. At this point some shareholders may be questioning thei...
How the Narrative Around Hikma Pharmaceuticals Is Shifting After Recent Analyst Target Moves
Hikma Pharmaceuticals’ latest valuation update points to a slightly lower fair value estimate of about $22.66 per share, even as analysts broadly maintain a constructive view on its long term growth...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
